|

Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer

RECRUITINGPhase 2Sponsored by West China Hospital
Actively Recruiting
PhasePhase 2
SponsorWest China Hospital
Started2026-09-28
Est. completion2027-01-31
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

To evaluate the efficacy and safety of superoxide dismutase skin spray for the reducing the acute radiation dermatitis in patients with head and neck malignancies undergoing radiotherapy.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Histologically confirmed malignant tumors of the head and neck without distant metastasis.
2. Scheduled to undergo either postoperative adjuvant radiotherapy or definitive radiotherapy, with or without concurrent chemotherapy.
3. Age 18-80 years at the time of consent.
4. Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
5. Signed informed consent form.
6. Adequate cognitive and reading abilities to complete the questionnaire.

Exclusion Criteria:

1. Pre-existing skin disease or open wounds in the irradiation field.
2. Have a history of head and neck radiotherapy.
3. Autoimmune or connective tissue disorders affecting skin.
4. Known allergy to any component of study formulations.
5. Any condition that, in the investigator's judgment, would interfere with study participation or outcome assessment.

Conditions2

CancerRadiation-induced Dermatitis

Interventions1

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.